Market Cap
₹7,833 Cr.
P/E
27.04
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
9.79%
3yr Average
12.74%
5yr Average
13.1%
Net Profit Margin
Latest
10.88%
3yr Average
15.88%
5yr Average
16.21%
ROCE
Latest
10.69%
3yr Average
14.16%
5yr Average
14.86%
Debt to Equity
Latest
0.0
3yr Average
0.0
5yr Average
0.0
Market Share
0.15% (as of Jul 22)
Anti - Diabetes - Market Share
2.78% (as of Jul 22)
Anti-Infectives - Market Share
0.03% (as of Feb 21)
Anti-Malarial - Market Share
0.75% (as of Nov 21)
Blood Related - Market Share
0.29% (as of Jul 22)
Cardiovascular - Market Share
0.54% (as of Nov 21)
Dermatology - Market Share
2.02% (as of Jul 22)
Gastro-Intestinal - Market Share
0.43% (as of Nov 21)
Gynecology - Market Share
0.15% (as of Nov 21)
Neurological - Market Share
3.30% (as of Nov 21)
Ophthalmology - Market Share
0.11% (as of Nov 21)
Pain - Market Share
1% (as of Dec 22)
Pharmaceutical Sector - Market Share
0.30% (as of Nov 21)
Respiratory - Market Share
6.12% (as of May 19)
Stomatological - Market Share
0.06% (as of Nov 21)
Urology - Market Share
0.79% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Formulation

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Bulk Drugs

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Electral
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis